|
 |
TadalafilThis page contains recent news articles, when available, and an overview of Tadalafil but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Tadalafil (when available) Tadalafil is used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH). Part of the physiological process of erection involves the release of nitric oxide (NO) in the corpus cavernosum. This then activates the enzyme guanylate cyclase which results in increased levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation in the corpus cavernosum, resulting in increased inflow of blood and an erection. Tadalafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum. This means that, with Tadalafil on board, normal sexual stimulation leads to increased levels of cGMP in the corpus cavernosum which leads to better erections. Without sexual stimulation and no activation of the NO/cGMP system, Tadalafil should not cause an erection. Used for the treatment of erectile dysfunction Mechanism Of Action: Tadalafil inhibits the cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum located around the penis. Penile erection during sexual stimulation is caused by increased penile blood flow resulting from the relaxation of penile arteries and corpus cavernosal smooth muscle. This response is mediated by the release of nitric oxide (NO) from nerve terminals and endothelial cells, which stimulates the synthesis of cGMP in smooth muscle cells. Cyclic GMP causes smooth muscle relaxation and increased blood flow into the corpus cavernosum. The inhibition of phosphodiesterase type 5 (PDE5) by Tadalafil enhances erectile function by increasing the amount of cGMP. News Articles on Tadalafil STEAM Dietary Supplements Recalled for Undeclared Drug Ingredient - Aug 24, 2009 Laboratory analysis of one lot of the supplements detected Tadalafil, the active ingredient in FDA-approved drugs for treatment of erectile dysfunction that Attorney at Law Sex sweets marketed as premium ginseng candy - Aug 25, 2009 ..."Investigations show that the manufacturer had intentionally mixed both compounds, sildenafil and tadalafil. "Although used to treat erectile dysfunction, AsiaOne STEAM Dietary Supplement Could Be Lethal - Aug 27, 2009 The FDA's statement warned that Steam contained a version of the drug called Tadalafil which is the main ingredient of the prescription erectile dysfunction UKMedix Health News The ENDOTRIAL Study: A spontaneous, open-label, randomized ... - Aug 5, 2009 The three effective, commercially available drugs for the treatment of erectile dysfunction-sildenafil, vardenafil, and tadalafil-inhibit the same substrate UroToday Obesity linked to brain shrinkage, erectile dysfunction - Aug 25, 2009 ..."mildly obese," with erectile dysfunction that is not relieved by the use of tadalafil, the erectile dysfunction medication better known as Cialis. Los Angeles Times A firmer erection is just a few mouse-clicks away - Aug 13, 2009 The runaway success of drugs such as Tadalafil, (marketed by Lilly under the brand name Cialis), and Sildenafil (marketed by Pfizer under the Viagra brand), PR CannaZine (press release) Taking Dex Can Improve High Altitude Exercise Capacity In Certain ... - Aug 13, 2009 ..."We have known that both tadalafil and dexamethasone are good for preventing high altitude pulmonary edema (HAPE) and dex for treating symptoms of acute Science Daily (press release) Buy Cialis Tadalafil High Quality Pills. The Most Popular Online - Aug 12, 2009 Cialis Tadalafil is one of the latest drugs for treating erectile dysfunction. You might know about Tadalafil that it is available under the brand name Erfassung und Verbreitung von Pressemitteilungen aus allen Branchen (Pressemitteilung) Link Between Erectile Dysfunction And Obesity Explored In Obesity ... - Aug 24, 2009 Even with the use of ED medication (tadalafil, Cialis, Eli Lilly), he was not able to achieve an erection adequate for intercourse. After dietary counseling Science Daily (press release) Consider Costs to Your Health Before Ordering ED Medication Online - Aug 26, 2009 Viagra and other erectile dysfunction medications such as Levitra (vardenafil) and Cialis (tadalafil) -- known as phosphodiesterase (PDE-5) inhibitors KFSM Pulmonary Hypertension; Health Law - Aug 14, 2009 ...subcutaneous and intravenous only) and marketed as Tyvaso; the other, Adcirca, contains tadalafil; that should ring a bell as a component of Cialis. Bisnow New Products: Rx, OTC, indications, and generics - Aug 7, 2009 United Therapeutics announced that the Food and Drug Administration (FDA) has approved Adcirca (tadalafil) tablets for oral administration, Modern Medicine Meet the Expert - Wayne JG Hellstrom - Aug 7, 2009 ...the oral phosphodiesterase type 5 inhibitors–tadalafil, vardenafil, and sildenafil–for the treatment of ED; premature ejaculation drugs; and a number of UroToday Take Dex and Climb Better at High Altitude - Aug 14, 2009 Subjects who took tadalafil and dexamethasone fared better in oxygen use than the placeo group, but the dex group had two major advantages. About - News & Issues Pinoy Kasi One tough woman - Aug 11, 2009 On the lighter side, Cipla has its own cheaper version of tadalafil, better known as Cialis, for erectile dysfunction. But let's get back to antiretrovirals Inquirer.net Product recalls - Aug 21, 2009 The Company has found by lab analysis that Lot 90260 contains Tadalafil, an active ingredient of an FDA-approved drug for erectile dysfunction (ED), The Associated Press Psychiatric Aspects of HIV Spectrum Disease - Aug 28, 2009 ...sildenafil, vardenafil, and tadalafil), there is a lack of specific prevention messages for this population. Finally, people with severe mental illness Focus (subscription) Hundreds Protest In Greenville Against Obama's Health Care Reform - Aug 10, 2009 Major drug maker, Eli Lilly manufacturers tadalafil and markets it under the brand name, Cialis. People believe Cialis to be the next generation of Viagra, WITN 'Dex' can improve high altitude exercise capacity - Aug 12, 2009 ...'We have known that both tadalafil and dexamethasone are good for preventing high altitude pulmonary edema (HAPE) and dex for treating symptoms of acute Argentina Star Malaysia: Thu giữ 68.000 gói kẹo kÃch dục có Ä‘á»™c - Aug 26, 2009 Ä?ược tiếp thị là loại kẹo sâm đặc biệt, loại kẹo nà y lại chứa chất sildenafil và tadalafil, các thà nh phần chÃnh chữa trị chứng rối loạn cÆ°Æ¡ng dÆ°Æ¡ng, 24 giờ Medicamento para disfunción eréctil alcanza ventas por 81 mdd ... - Aug 13, 2009 Tadalafil sigue en aumento, y para junio de este año “logramos ya una cifra de ventas que alcanza los 81 millones de dólares anualizadosâ€?. Milenio Los pasos de los pesos(César Castruita | ) - Aug 21, 2009 ...donde el laboratorio Eli Lilly México, que comanda Carlos Baños con su medicamento Cialis (Tadalafil), tratamiento para disfunción eréctil, se convirtió La Crónica de Hoy MOTO GP: DISFUNZIONE ERETTILE: UN PROBLEMA NON SOLO MASCHILE - Aug 11, 2009 Negli anni successivi si sono aggiunti altri due farmaci: il Vardenafil ed il Tadalafil. Il meccanismo d'azione è simile per tutti e tre, e tutti hanno Moto GP blog Saisie de faux Viagra - Aug 8, 2009 Deux autres médicaments ayant sensiblement les mêmes effets ont été approuvés en 2003: le vardenafil (Levitra) et le tadalafil (Cialis). Canoë Obat kuat berbahaya masih beredar di pasaran - Aug 27, 2009 Anis menerangkan, produk itu dilarang beredar karena mengandung zat sildenafil sitrat dan tadalafil, yang berbahaya bagi kesehatan. Waspada Online Ratusan Obat Kuat dan Alat Bantu Seks Disita - Aug 20, 2009 Obat-obatan yang berhasil disita meliputi, viagra, vialis, Sidenafil, dan Tadalafil. Selain obat kuat, petugas juga menyita berbagai alat peraga atau alat Berita Jakarta Thuốc chữa bệnh “chÆ°a đến chợ đã hết tiá»?nâ€? - Aug 17, 2009 ...nhóm chống trầm cảm ba vòng (clomipramin), nhóm an thần, nhóm chẹn alpha giao cảm, hay nhóm ức chế PDE5 (sildenafil, tadalafil, vardenafil). 24 giờ Lo sport aiuta l'amore - Aug 5, 2009 Il primo trattato solo con inibitore PDE-5 (sildenafil, tadalafil o vardenafil) e il secondo con inibitore PDE-5 in aggiunta a un'attività sportiva aerobica L'Espresso 'El viagra también sirve para las mujeres' - Aug 7, 2009 Eso ha llevado a que el sildenafil, vardenafil y tadalafil se conviertan en drogas prácticamente recreativas que usan grupos de edad desde los 18 años hasta El Espectador (Colombia) Zollfahnder suchen nach gefälschten Medikamenten - Aug 10, 2009 120000 Euro bei sich; täuschend echte Zehnerpackungen „Cialis“ mit jeweils 20 Milligramm des Wirkstoffs Tadalafil des britischen Produzenten Lilly. Berliner Morgenpost Ä‚n gừng lợi hÆ¡n uống Viagra - Aug 8, 2009 Vá»? danh nghÄ©a, các viên Viagra (Sildenafil), Levitra (Vardenafil), Cialis (Tadalafil) được phép bán theo Ä‘Æ¡n bác sÄ©. NhÆ°ng ở xứ ta chÆ°a quen coi trá»?ng cái Tiền Phong Online Khi chà ng 'yếu kém' - Aug 4, 2009 Phổ biến nhất và hay dùng nhất là dùng thuốc (thuốc uống nhÆ° Viagra, Tadalafil,…, thuốc đặt niệu đạo, thuốc tiêm...), sau đó dùng bá»™ dụng cụ bÆ¡m hút chân Thời Báo Việt Brand Names/Synonyms: Tadalafil is also known by the following brand names and/or synonymsCIA; Cialis; Cialis/Tadalafil Hcl; Cialis/Taladafil; IC 351; ICOS 351; Tadalafil; Tadanafil Drug Category: Tadalafil is categorized under the following by the FDA: Vasoconstrictor Agents; Phosphodiesterase Inhibitors; ATC:G04BE08 Dosage Forms: TABLET Absorption: After single oral-dose administration, the maximum observed plasma concentration (Cmax) of tadalafil is achieved between 30 minutes and 6 hours (median time of 2 hours). Absolute bioavailability of tadalafil following oral dosing has not been determined. Interactions: Interactions for Tadalafil: Effects of Other Drugs on Tadalafil Cytochrome P450 Inhibitors: Tadalafil is a substrate of and predominantly metabolized by CYP3A4. Studies have shown that drugs that inhibit CYP3A4 can increase tadalafil exposure. Ketoconazole (400 mg daily), a selective and potent inhibitor of CYP3A4, increased tadalafil 20-mg single-dose exposure (AUC) by 312% and Cmax by 22%, relative to the values for tadalafil 20 mg alone. Ketoconazole (200 mg daily) increased tadalafil 10-mg single-dose exposure (AUC) by 107% and Cmax by 15%, relative to the values for tadalafil 10 mg alone. HIV Protease inhibitor: Ritonavir (200 mg twice daily), an inhibitor of CYP3A4, CYP2C9, CYP2C19, and CYP2D6, increased tadalafil 20-mg single-dose exposure (AUC) by 124% with no change in Cmax, relative to the values for tadalafil 20 mg alone. Although specific interactions have not been studied, other HIV protease inhibitors would likely increase tadalafil exposure. Based upon these results, in patients taking concomitant potent CYP3A4 inhibitors, the dose of Tadalafil should not exceed 10 mg, and Tadalafil should not be taken more frequently than once in every 72 hours. Other cytochrome P450 inhibitors: Although specific interactions have not been studied, other CYP3A4 inhibitors, such as erythromycin, itraconazole, and grapefruit juice, would likely increase tadalafil exposure. Cytochrome P450 Inducers: Studies have shown that drugs that induce CYP3A4 can decrease tadalafil exposure. Rifampin: Rifampin (600 mg daily), a CYP3A4 inducer, reduced tadalafil 10-mg single-dose exposure (AUC) by 88% and Cmax by 46%, relative to the values for tadalafil 10 mg alone. Although specific interactions have not been studied, other CYP3A4 inducers, such as carbamazepine, phenytoin, and phenobarbitol, would likely decrease tadalafil exposure. No dose adjustment is warranted. Gastrointestinal Drugs: H2 antagonists: An increase in gastric pH resulting from administration of nizatidine had no significant effect on tadalafil pharmacokinetics. Antacids: Simultaneous administration of an antacid (magnesium hydroxide/aluminum hydroxide) and tadalafil reduced the apparent rate of absorption of tadalafil without altering exposure (AUC) to tadalafil. Effects of Tadalafil on Other Drugs: Drugs Metabolized by Cytochrome P450 Tadalafil is not expected to cause clinically significant inhibition or induction of the clearance of drugs metabolized by cytochrome P450 (CYP) isoforms. Studies have shown that tadalafil does not inhibit or induce P450 isoforms CYP1A2, CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP2E1. CYP1A2 substrate: Tadalafil had no clinically significant effect on the pharmacokinetics of theophylline. When tadalafil was administered to subjects taking theophylline, a small augmentation (3 beats per minute) of the increase in heart rate associated with theophylline was observed. CYP3A4 substrates: Tadalafil had no clinically significant effect on exposure (AUC) to midazolam or lovastatin. CYP2C9 substrate: Tadalafil had no clinically significant effect on exposure (AUC) to S-warfarin or R-warfarin, nor did tadalafil affect changes in prothrombin time induced by warfarin. Alcohol Alcohol and PDE5 inhibitors, including tadalafil, are mild systemic vasodilators. The interaction of tadalafil with alcohol was evaluated in 3 clinical pharmacology studies. In 2 of these, alcohol was administered at a dose of 0.7 g/kg, which is equivalent to approximately 6 ounces of 80-proof vodka in an 80-kg male, and tadalafil was administered at a dose of 10 mg in 1 study and 20 mg in another. In both these studies, all patients imbibed the entire alcohol dose within 10 minutes of starting. In one of these two studies, blood alcohol levels of 0.08% were confirmed. In these two studies, more patients had clinically significant decreases in blood pressure on the combination of tadalafil and alcohol as compared to alcohol alone. Some subjects reported postural dizziness, and orthostatic hypotension was observed in some subjects. When tadalafil 20 mg was administered with a lower dose of alcohol (0.6 g/kg, which is equivalent to approximately 4 ounces of 80-proof vodka, administered in less than 10 minutes), orthostatic hypotension was not observed, dizziness occurred with similar frequency to alcohol alone, and the hypotensive effects of alcohol were not potentiated. Tadalafil did not affect alcohol plasma concentrations and alcohol did not affect tadalafil plasma concentrations. Both alcohol and Tadalafil, a PDE5 inhibitor, act as mild vasodilators. When mild vasodilators are taken in combination, blood-pressure-lowering effects of each individual compound may be increased. Substantial consumption of alcohol (e.g., 5 units or greater) in combination with Tadalafil can increase the potential for orthostatic signs and symptoms, including increase in heart rate, decrease in standing blood pressure, dizziness, and headache. Anti-Hypertensives PDE5 inhibitors, including tadalafil, are mild systemic vasodilators. Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected anti-hypertensive medications. Alpha Blockers Doxazosin: When tadalafil 20 mg was administered to healthy subjects taking doxazosin (8 mg daily), an alpha[1]-adrenergic blocker, there was significant augmentation of the blood-pressure-lowering effect of doxazosin. Tamsulosin: In a clinical pharmacology study, when a single dose of tadalafil 20 mg was administered to healthy subjects taking 0.4 mg once-daily tamsulosin, a selective alpha[1A]-adrenergic blocker, no significant decreases in blood pressure were observed. Therefore, based upon significant augmentation of the blood-pressure-lowering effect of doxazosin, an alpha[1]-adrenergic blocker, and no significant effect seen with 0.4 mg once-daily tamsulosin, a selective alpha[1A]-adrenergic blocker, administration of Tadalafil to patients taking any alpha-adrenergic blocker other than 0.4 mg once-daily tamsulosin is contraindicated. Other Anti-Hypertensive Agents Amlodipine: A study was conducted to assess the interaction of amlodipine (5 mg daily) and tadalafil 10 mg. There was no effect of tadalafil on amlodipine blood levels and no effect of amlodipine on tadalafil blood levels. The mean reduction in supine systolic/diastolic blood pressure due to tadalafil 10 mg in subjects taking amlodipine was 3/2 mm Hg, compared to placebo. In a similar study using tadalafil 20 mg, there were no clinically significant differences between tadalafil and placebo in subjects taking amlodipine. Metoprolol: A study was conducted to assess the interaction of sustained-release metoprolol (25 to 200 mg daily) and tadalafil 10 mg. Following dosing, the mean reduction in supine systolic/diastolic blood pressure due to tadalafil 10 mg in subjects taking metoprolol was 5/3 mm Hg, compared to placebo. Bendrofluazide: A study was conducted to assess the interaction of bendrofluazide (2.5 mg daily) and tadalafil 10 mg. Following dosing, the mean reduction in supine systolic/diastolic blood pressure due to tadalafil 10 mg in subjects taking bendrofluazide was 6/4 mm Hg, compared to placebo. Enalapril: A study was conducted to assess the interaction of enalapril (10 to 20 mg daily) and tadalafil 10 mg. Following dosing, the mean reduction in supine systolic/diastolic blood pressure due to tadalafil 10 mg in subjects taking enalapril was 4/1 mm Hg, compared to placebo. Angiotensin II receptor blocker (and other anti-hypertensives): A study was conducted to assess the interaction of angiotensin II receptor blockers and tadalafil 20 mg. Subjects in the study were taking any marketed angiotensin II receptor blocker, either alone, as a component of a combination product, or as part of a multiple anti-hypertensive regimen. Following dosing, ambulatory measurements of blood pressure revealed differences between tadalafil and placebo of 8/4 mm Hg in systolic/diastolic blood pressure. Aspirin Tadalafil did not potentiate the increase in bleeding time caused by aspirin. Chemical IUPAC Name: (6R-trans)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |